TIDES USA 2022 – Hybrid Event

TIDES USA 2022 – Hybrid Event
by
223 223 people viewed this event.
Oligonucleotide & Peptide Therapeutics
Meet us on the TIDES USA 2022 delivered as a hybrid event and includes 150+ of the industry’s top scientists sharing their experience in cutting-edge science and progress. The entire spectrum from discovery, preclinical, clinical development through to manufacturing and commercialization of therapeutics such as oligos, peptides mRNA and genome editing products.